Sleep desaturation and its relationship to lung function, exercise and quality of life in LAM

Carregando...
Imagem de Miniatura
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
W B SAUNDERS CO LTD
Citação
RESPIRATORY MEDICINE, v.106, n.3, p.420-428, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Lymphangioleiomyomatosis (LAM) is characterised by progressive airway obstruction and hypoxaemia in young women. Although sleep may trigger hypoxaemia in patients with airway obstruction, it has not been previously investigated in patients with LAM. Methods: Consecutive women with lung biopsy proven LAM and absence of hypoxaemia while awake were evaluated with pulmonary function test, echocardiography, 6-min walk test, overnight full polysomnography, and Short Form 36 health-related quality-of-life questionnaire. Results: Twenty-five patients with (mean +/- SD) age 45 +/- 10 years, SpO(2) awake 95% +/- 2, forced expiratory volume in the first second (median-interquartile) FEV1 (% predicted) 77 (47-90) and carbonic monoxide diffusion capacity, DLCO (%) 55 (34-74) were evaluated. Six-minute walk test distance and minimum SpO(2) (median-interquartile) were, respectively, 447 m (411 -503) and 90% (82-94). Median interquartile apnoea-hypopnoea index was in the normal range 2 (1-5). Fourteen patients (56%) had nocturnal hypoxaemia (10% total sleep time with SpO(2) <90%), and the median sleep time spent with SpO(2) <90% was 136 (13-201) min. Sleep time spent with SpO(2) <90% correlated with the residual volume/total lung capacity ratio (r(s) = 0.5, p: 0.02), DLCO (r(s) = -0.7, p: 0.001), FEV1 (r(s) = -0.6, p: 0.002). Multivariate linear regression model showed that RV/TLC ratio was the most important functional variable related to sleep hypoxaemia. Conclusion: Significant hypoxaemia during sleep is common in LAM patients with normal SpO(2) while awake, especially among those with some degree of hyperinflation in lung function tests. (C) 2011 Published by Elsevier Ltd.
Palavras-chave
Lymphangioleio myomatosis (LAM), Polysomnography, Sleep hypoxaemia, Six-minute walk test, Lung function test
Referências
  1. BALLARD RD, 1995, AM J RESP CRIT CARE, V151, P945
  2. Becker HF, 1999, AM J RESP CRIT CARE, V159, P112
  3. Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564
  4. BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012
  5. BOYSEN PG, 1979, CHEST, V76, P536, DOI 10.1378/chest.76.5.536
  6. Carvalho CRR, 2004, J BRAS PNEUMOL, V30, P66
  7. CATTERALL JR, 1983, AM REV RESPIR DIS, V128, P24
  8. Ciconelli PM, 1999, REV BRAS REUMATOL, V39, P143
  9. Dancey DR, 2001, CHEST, V120, P151, DOI 10.1378/chest.120.1.151
  10. DEMARCO FJ, 1981, CHEST, V79, P621, DOI 10.1378/chest.79.6.621
  11. DOUGLAS NJ, 1992, CLIN CHEST MED, V13, P523
  12. Drager LF, 2007, CHEST, V131, P1379, DOI 10.1378/chest.06-2703
  13. Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384
  14. Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488
  15. GRASSINO A, 1984, ANNU REV MED, V35, P625, DOI 10.1146/annurev.med.35.1.625
  16. Gries RE, 1996, CHEST, V110, P1489, DOI 10.1378/chest.110.6.1489
  17. JOHNS MW, 1991, SLEEP, V14, P540
  18. Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209
  19. Johnson SR, 2000, THORAX, V55, P1052, DOI 10.1136/thorax.55.12.1052
  20. Kelly J, 2001, AM J MED SCI, V321, P17, DOI 10.1097/00000441-200101000-00004
  21. KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725
  22. Lama VN, 2003, AM J RESP CRIT CARE, V168, P1084, DOI 10.1164/rccm.200302-219OC
  23. LITTNER MR, 1980, AM REV RESPIR DIS, V122, P849
  24. MAHLER DA, 1984, CHEST, V85, P751, DOI 10.1378/chest.85.6.751
  25. Marcos E, 2003, AM J RESP CRIT CARE, V168, P487, DOI 10.1164/rccm.200210-1212OC
  26. Mohsenin V, 2005, SEM RESP CRIT CARE M, V26, P109, DOI 10.1055/s-2005-864204
  27. Moses MA, 2006, NEW ENGL J MED, V354, P2621, DOI 10.1056/NEJMc053410
  28. Neder JA, 1999, BRAZ J MED BIOL RES, V32, P729
  29. Netzer NC, 1999, ANN INTERN MED, V131, P485
  30. Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205
  31. Pereira CAC, 2002, J PNEUMOL S3, V28
  32. PHILLIPSON EA, 1978, AM REV RESPIR DIS, V118, P909
  33. Pimenta SP, 2011, J BRAS PNEUMOL, V37, P424
  34. Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC
  35. Sullivan EJ, 1998, CHEST, V114, P1689, DOI 10.1378/chest.114.6.1689
  36. TARPY SP, 1995, NEW ENGL J MED, V333, P710, DOI 10.1056/NEJM199509143331107
  37. Taveira DaSilva AM, 2003, AM J RESP CRIT CARE, V168, P1427
  38. TAYLOR JR, 1990, NEW ENGL J MED, V323, P1254, DOI 10.1056/NEJM199011013231807
  39. West SD, 2009, BRIT MED J, V7, P338
  40. Zimmermann CS, 2007, BRAZ J MED BIOL RES, V40, P179, DOI 10.1590/S0100-879X2006005000056
  41. [Anonymous], 2002, AM J RESP CRIT CARE, V166, P111
  42. [Anonymous], 2004, DIRETRIZES INDICACOE, V82, P11